BIOCYTICS AND EREMID GENOMIC SERVICES COLLABORATE ON RESEARCH STUDY FOR NOVEL SINGLE-CELL TRANSCRIPTOMICS IMMUNE-BASED CANCER CELL THERAPY

PartnershipPositive

AI Analysis

Summary

BioCytics engaged Eremid Genomic Services to perform single-cell transcriptomic sequencing on an autologous immune cell fraction as part of its immune-based cancer cell therapy development efforts.

Importance:5/10

Sentiment:

0.30

partnershipcollaborationgenomic servicessingle-cell transcriptomicsautologous immune cell therapycancer

Read the original article

Published by PR Newswire Clinical Trials on September 18, 2026 3:50 PM

Read Original